ArticleGenetics and molecular biology2025
Identification and interaction analysis of hubgenes related to neutrophil ferroptosis in intracranial atherosclerotic stenosis.
Article in Genetics and molecular biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Circulating neutrophils and ferroptosis are vital for the development of intracranial atherosclerotic stenosis (ICAS). This study aimed to explore that whether neutrophil ferroptosis participate in ICAS. Sixteen patients with ICAS and 14 healthy controls were enrolled. We collected peripheral blood and separated neutrophils. LncRNA, mRNA, and miRNA sequencing were performed. The differently expressed (DE) lncRNAs, mRNAs, and miRNAs were selected. The protein-protein interaction (PPI) network was constructed, top 30 hubgenes were selected, and intersected with DE ferroptosis genes to obtain the core genes. Combined with DE lncRNAs and miRNAs, the ceRNA network and TF-miRNA-mRNA network were constructed. Finally, the expression levels of the core genes were verified by Quantitative Reverse Transcription PCR (qRT-PCR) in other 11 patients and 9 healthy controls. The five core ferroptosis hubgenes were preliminarily identified, and ceRNA network and TF-miRNA-mRNA network were constructed. We identified several pairs of interactions. Finally, verification of qRT-PCR results revealed that CTSB (P=0.001) and HNRNPL (P=0.002) were upregulated, KRAS (P=0.003) and MAP1LC3A (P=0.004) were downregulated in ICAS group, compared with healthy controls. Our results identified four core genes (CTSB, HNRNPL, KRAS and MAP1LC3A) and constructed potential regulatory network, providing the potential therapeutic targets for ICAS.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.